Back
Speaker illustration

undefined undefined undefined

Presentations Articles

Adherence and discontinuation of sglt2-inhibitors and glp1-r agonists in patients with type 2 diabetes with and without cardiovascular disease

Event: ESC Congress 2022

Topic: Antidiabetic Pharmacotherapy

Session: Anti-diabetic pharmacotherapy in clinical practice

Access
Like
Thumbnail

The impact of statins and RAS inhibitors on the association between delayed antidiabetic treatment and the risk of cardiovascular event in patients with a first HbA1c between 48-57 mmol/mol

Event: ESC Congress 2022

Topic: Pharmacotherapy

Session: Diabetes and the heart 2

Access
Like
Thumbnail

Socioeconomic position and initiation of SGLT-2 inhibitors or GLP-1 receptor agonists in patients with type 2 diabetes - a Danish nationwide observational study

Event: ESC Congress 2021 - The Digital Experience

Topic: Diabetes and the Heart

Session: Risk Factors and Prevention ePosters

Access
Like
Thumbnail

Socioeconomic position influences the risk of first-time cardiovascular event in patients with type 2 diabetes in spite of equal access to healthcare - a Danish nationwide cohort study

Event: ESC Congress 2020

Topic: Epidemiology

Session: Cardiovascular Involvement in pre-Diabetes

Access
Like
Thumbnail

Copeptin - a marker of short- and long-term mortality in patients with ST-segment elevation myocardial infarction

Event: ESC Congress 2017

Topic: Biomarkers

Session: Adverse outcome in patients with cardiometabolic disorders

Access
Like
Thumbnail

ESC 365 is supported by

novartis Explore sponsored resources